Loading...

Santhera Pharmaceuticals Holding AG

SPHDF•PNK
Healthcare
Biotechnology
$23.25
$0.40(1.75%)
U.S. Market opens in 2h 9m

Santhera Pharmaceuticals Holding AG (SPHDF) Stock Overview

Explore Santhera Pharmaceuticals Holding AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap330.6M
P/E Ratio-3.59
EPS (TTM)$-6.84
ROE-5.22%
Fundamental Analysis

AI Price Forecasts

1 Month$20.85
3 Months$21.40
1 Year Target$114961.42

SPHDF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Santhera Pharmaceuticals Holding AG (SPHDF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 84.04, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $114961.42.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.59 and a market capitalization of 330.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.75%
5-Day Change
5.92%
1-Month Change
18.62%
3-Month Change
48.75%
6-Month Change
89.49%
Year-to-Date (YTD) Change
74.16%
1-Year Change
32.55%
3-Year Change
-96.58%
5-Year Change
-20.65%
All-Time (Max) Change
51666666566.67%

Contact Information

https://www.santhera.com
41 61 906 89 50
Hohenrainstrasse 24, Pratteln, NaN, 4133

Company Facts

78 Employees
IPO DateApr 17, 2014
CountryCH
Actively Trading

Frequently Asked Questions